Clinical Trials Browser

Sinonasal Squamous Cell Carcinoma

Oropharyngeal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Pathologic Complete Response, Rectal Neoplasms

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Infiltrating Bladder Urothelial Carcinoma

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Nasopharyngeal Carcinoma

Rectal Neoplasms

Resectable Esophageal Cancer

Pancreatic Cancer Non-resectable

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Hypopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Oropharyngeal Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Small Cell Lung Carcinoma

Glioblastoma

Esophageal Neoplasms

Esophageal Neoplasms

Rectal Malignant Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Uterine Cervical Neoplasms

Clinical Trials

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

(NeoScorch HN)

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

SOLAR

FAIR

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

InDuRanS

PANC

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

G-CSF After Chemo-radiation in Patients With Glioblastoma

Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

ACCESS

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

OPTIMA-II

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer